[
    [
        {
            "time": "",
            "orginal_text": "携手药明康德、林向红创建并购基金：刘晓丹如何再创并购佳绩？",
            "features": {
                "keywords": [
                    "药明康德",
                    "并购基金",
                    "刘晓丹"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "并购"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "携手药明康德、林向红创建并购基金：刘晓丹如何再创并购佳绩？",
            "scores": {
                "News_content": "携手药明康德、林向红创建并购基金：刘晓丹如何再创并购佳绩？",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "orginal_text": "打了生长激素！“药中茅台”长春高新去年大丰收，九成净利来自“长子”金赛药业",
            "features": {
                "keywords": [
                    "长春高新",
                    "金赛药业",
                    "生长激素"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "打了生长激素！“药中茅台”长春高新去年大丰收，九成净利来自“长子”金赛药业",
            "scores": {
                "News_content": "打了生长激素！“药中茅台”长春高新去年大丰收，九成净利来自“长子”金赛药业",
                "Correlation": 3,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "orginal_text": "市场要闻 | “血茅”华兰生物去年净利增逾2成，但新冠疫苗进展不顺？",
            "features": {
                "keywords": [
                    "华兰生物",
                    "新冠疫苗",
                    "净利润增长"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "mixed",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "市场要闻 | “血茅”华兰生物去年净利增逾2成，但新冠疫苗进展不顺？",
            "scores": {
                "News_content": "市场要闻 | “血茅”华兰生物去年净利增逾2成，但新冠疫苗进展不顺？",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "40股今日获机构买入评级",
            "features": {
                "keywords": [
                    "机构买入评级",
                    "股票"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "40股今日获机构买入评级",
            "scores": {
                "News_content": "40股今日获机构买入评级",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "西部证券：华兰生物（002007.SZ）全年业绩稳健增长，维持“买入”评级",
            "features": {
                "keywords": [
                    "华兰生物",
                    "西部证券",
                    "买入评级"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "西部证券：华兰生物（002007.SZ）全年业绩稳健增长，维持“买入”评级",
            "scores": {
                "News_content": "西部证券：华兰生物（002007.SZ）全年业绩稳健增长，维持“买入”评级",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "国信证券：华兰生物（002007.SZ）血制品和流感疫苗的双龙头，维持“买入”评级",
            "features": {
                "keywords": [
                    "华兰生物",
                    "国信证券",
                    "血制品",
                    "流感疫苗"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "国信证券：华兰生物（002007.SZ）血制品和流感疫苗的双龙头，维持“买入”评级",
            "scores": {
                "News_content": "国信证券：华兰生物（002007.SZ）血制品和流感疫苗的双龙头，维持“买入”评级",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "光大证券 - 华兰生物2020年业绩快报点评：业绩符合预期，四价流感疫苗强劲增长【公司研究】",
            "features": {
                "keywords": [
                    "华兰生物",
                    "光大证券",
                    "四价流感疫苗"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "光大证券 - 华兰生物2020年业绩快报点评：业绩符合预期，四价流感疫苗强劲增长【公司研究】",
            "scores": {
                "News_content": "光大证券 - 华兰生物2020年业绩快报点评：业绩符合预期，四价流感疫苗强劲增长【公司研究】",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "资本市场多措并举 支持上市公司做优做强",
            "features": {
                "keywords": [
                    "资本市场",
                    "上市公司",
                    "政策支持"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "资本市场多措并举 支持上市公司做优做强",
            "scores": {
                "News_content": "资本市场多措并举 支持上市公司做优做强",
                "Correlation": 2,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "晨会聚焦210312重点关注万国数据、华兰生物",
            "features": {
                "keywords": [
                    "华兰生物",
                    "万国数据",
                    "晨会聚焦"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "晨会聚焦210312重点关注万国数据、华兰生物",
            "scores": {
                "News_content": "晨会聚焦210312重点关注万国数据、华兰生物",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "orginal_text": "华兰生物（002007）2020年业绩快报点评：疫苗快速放量，血制品业务企稳",
            "features": {
                "keywords": [
                    "华兰生物",
                    "疫苗",
                    "血制品"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "华兰生物（002007）2020年业绩快报点评：疫苗快速放量，血制品业务企稳",
            "scores": {
                "News_content": "华兰生物（002007）2020年业绩快报点评：疫苗快速放量，血制品业务企稳",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "“并购女王”又出手！药明康德联手刘晓丹，设立医疗并购基金",
            "features": {
                "keywords": [
                    "并购女王",
                    "药明康德",
                    "医疗并购基金"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "并购"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "“并购女王”又出手！药明康德联手刘晓丹，设立医疗并购基金",
            "scores": {
                "News_content": "“并购女王”又出手！药明康德联手刘晓丹，设立医疗并购基金",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        }
    ]
]